Change management and re-qualification MCQs with Answer is designed for M.Pharm students to reinforce key concepts in pharmaceutical validation related to controlling changes and determining when re-qualification is needed. This resource focuses on regulatory expectations, risk-based impact assessment, documentation practices, and practical triggers for re-validation of equipment, utilities, processes and computerized systems. The questions emphasize root-cause analysis, acceptance criteria, qualification stages (IQ/OQ/PQ), and examples of changes that may or may not require re-qualification. Use these MCQs to test understanding, prepare for exams, and apply principles of robust change control and lifecycle management in regulated pharmaceutical environments.
Q1. What is the primary objective of a formal change control process in pharmaceutical validation?
- To minimize paperwork associated with changes
- To manage and document changes to ensure product quality and regulatory compliance
- To speed up manufacturing by allowing rapid untracked changes
- To outsource validation activities to vendors
Correct Answer: To manage and document changes to ensure product quality and regulatory compliance
Q2. Which of the following is NOT typically considered a trigger for re-qualification of equipment?
- Major mechanical modification to the equipment
- Relocation of equipment to a different room with altered utilities
- Routine preventive maintenance performed as scheduled
- Change in critical process parameter causing different stress on equipment
Correct Answer: Routine preventive maintenance performed as scheduled
Q3. In change management, the best practice to assess the potential impact of a proposed change is to perform:
- An arbitrary decision by the production supervisor
- A formal risk assessment using tools such as FMEA or HACCP principles
- A survey of operators for opinions
- An immediate implementation followed by retrospective review
Correct Answer: A formal risk assessment using tools such as FMEA or HACCP principles
Q4. Which validation lifecycle document should describe policies for change control and re-qualification frequency?
- Batch production record
- Validation Master Plan (VMP)
- Purchase order
- Marketing authorization dossier
Correct Answer: Validation Master Plan (VMP)
Q5. Which type of change requires prospective validation before commercial use?
- Non-critical cosmetic change to documentation
- Change that affects a critical quality attribute or critical process parameter
- Minor change in vendor address
- Change in stationery supplier
Correct Answer: Change that affects a critical quality attribute or critical process parameter
Q6. After a corrective action for an out-of-specification (OOS) result, re-validation is most commonly driven by:
- The cost of the corrective action
- The potential impact of the root cause on product quality and process performance
- The availability of validation staff
- The desire to avoid documenting changes
Correct Answer: The potential impact of the root cause on product quality and process performance
Q7. What is the correct sequence of qualification activities for newly installed equipment?
- PQ → OQ → IQ
- IQ → PQ → OQ
- IQ → OQ → PQ
- OQ → IQ → PQ
Correct Answer: IQ → OQ → PQ
Q8. Which documentation should be updated as part of implementing a validated change?
- Only the change request form
- All affected controlled documents including SOPs, validation protocols, and drawings
- Only training records
- No documentation is required if the change is small
Correct Answer: All affected controlled documents including SOPs, validation protocols, and drawings
Q9. For a computerised system change, which activity is essential before re-deployment?
- Only a speed test by IT
- Risk assessment, impact analysis, change control, and appropriate re-validation/testing
- Informal verbal approval from a supervisor
- Deletion of user access controls
Correct Answer: Risk assessment, impact analysis, change control, and appropriate re-validation/testing
Q10. Periodic re-qualification of utilities (e.g., HVAC, purified water) is primarily intended to:
- Generate additional reports for auditors
- Verify continued performance against original acceptance criteria and detect drift
- Delay corrective maintenance
- Replace preventive maintenance tasks
Correct Answer: Verify continued performance against original acceptance criteria and detect drift
Q11. Which of the following changes would most likely be handled as a minor change with documentation but without re-qualification?
- Change of a heating element in a reactor that alters temperature uniformity
- Replacement of a non-critical, like-for-like instrument cable at the same location
- Relocating the tablet compression line to another cleanroom
- Change in formulation excipient supplier affecting impurity profile
Correct Answer: Replacement of a non-critical, like-for-like instrument cable at the same location
Q12. Which regulator guidance specifically emphasizes lifecycle approach to validation and managing changes?
- ICH Q7 – Good Manufacturing Practice Guide for Active Pharmaceutical Ingredients
- ICH Q10 – Pharmaceutical Quality System
- WHO GMP Annex 7
- None of the above
Correct Answer: ICH Q10 – Pharmaceutical Quality System
Q13. Re-qualification after equipment relocation should include which of the following steps at minimum?
- Only visual inspection
- IQ, appropriate OQ tests addressing utilities and environmental differences, and PQ if process is affected
- Only updating the equipment tag
- Skip qualification if the relocation is within the same building
Correct Answer: IQ, appropriate OQ tests addressing utilities and environmental differences, and PQ if process is affected
Q14. Which tool is commonly used to prioritize validation activities and decide if a change requires re-validation?
- FMEA (Failure Modes and Effects Analysis)
- Random sampling of documents
- Opinion polls among staff
- Marketing analysis
Correct Answer: FMEA (Failure Modes and Effects Analysis)
Q15. When a supplier changes a component material, the change control evaluation should include:
- Only a price comparison
- Assessment of supplier change notification, material specification, impact on critical quality attributes, and need for testing/re-validation
- Immediate switch without documentation
- Stopping production permanently
Correct Answer: Assessment of supplier change notification, material specification, impact on critical quality attributes, and need for testing/re-validation
Q16. Which acceptance criterion principle should guide re-qualification test limits after a change?
- Arbitrary tighter limits to avoid future failures
- Limits based on validated process capability, scientific justification, and regulatory expectations
- Use of the broadest possible limits to pass tests easily
- No criteria are required if tests are performed
Correct Answer: Limits based on validated process capability, scientific justification, and regulatory expectations
Q17. A retrospective change control approach is acceptable when:
- Change could significantly affect product quality
- Change is low-risk, well-documented, and within documented policy allowing retrospective evaluation
- There is no time to perform any assessment
- When the change involves critical process parameters
Correct Answer: Change is low-risk, well-documented, and within documented policy allowing retrospective evaluation
Q18. Which of the following best describes “re-validation” in the context of pharmaceutical processes?
- Re-running full commercial batches for marketing purposes
- Executing a set of planned activities to demonstrate that a process or system remains in a state of control after a change or over time
- Deleting old validation records
- Only re-training operators
Correct Answer: Executing a set of planned activities to demonstrate that a process or system remains in a state of control after a change or over time
Q19. When is a partial re-qualification generally appropriate?
- When the change affects only certain functions or subsystems and a full re-qualification is not justified by risk assessment
- When management wants to save money regardless of risk
- When the entire facility has been rebuilt
- Always, irrespective of change impact
Correct Answer: When the change affects only certain functions or subsystems and a full re-qualification is not justified by risk assessment
Q20. Which activity supports evidence that re-qualification is not required after a change?
- An opinionated email from production staff
- Documented impact assessment, risk analysis, historical performance data, and justification in change control record
- Immediate implementation with no documentation
- Only a phone call to the supplier
Correct Answer: Documented impact assessment, risk analysis, historical performance data, and justification in change control record

I am a Registered Pharmacist under the Pharmacy Act, 1948, and the founder of PharmacyFreak.com. I hold a Bachelor of Pharmacy degree from Rungta College of Pharmaceutical Science and Research. With a strong academic foundation and practical knowledge, I am committed to providing accurate, easy-to-understand content to support pharmacy students and professionals. My aim is to make complex pharmaceutical concepts accessible and useful for real-world application.
Mail- Sachin@pharmacyfreak.com
